Completeness of adverse drug reactions reports of the Saudi adverse event reporting system

From the Department of Clinical Pharmacy (Alshammari), College of Pharmacy, University of Hail, Hail, the Medication Safety Research Chair (Alshammari, Aljadhey), College of Pharmacy, King Saud University, the Department of Clinical Pharmacy (Al-Kathiri, Aljadhey), College of Pharmacy, King Saud University, the Pharmacy Service (Al-Kathiri, Aljadhey), King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia, and the Pharmacovigilance Department (Le Louet), Henri Mondor University Hospital (AP-HP), Créteil, France

From the Department of Clinical Pharmacy (Alshammari), College of Pharmacy, University of Hail, Hail, the Medication Safety Research Chair (Alshammari, Aljadhey), College of Pharmacy, King Saud University, the Department of Clinical Pharmacy (Al-Kathiri, Aljadhey), College of Pharmacy, King Saud University, the Pharmacy Service (Al-Kathiri, Aljadhey), King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia, and the Pharmacovigilance Department (Le Louet), Henri Mondor University Hospital (AP-HP), Créteil, France

From the Department of Clinical Pharmacy (Alshammari), College of Pharmacy, University of Hail, Hail, the Medication Safety Research Chair (Alshammari, Aljadhey), College of Pharmacy, King Saud University, the Department of Clinical Pharmacy (Al-Kathiri, Aljadhey), College of Pharmacy, King Saud University, the Pharmacy Service (Al-Kathiri, Aljadhey), King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia, and the Pharmacovigilance Department (Le Louet), Henri Mondor University Hospital (AP-HP), Créteil, France

From the Department of Clinical Pharmacy (Alshammari), College of Pharmacy, University of Hail, Hail, the Medication Safety Research Chair (Alshammari, Aljadhey), College of Pharmacy, King Saud University, the Department of Clinical Pharmacy (Al-Kathiri, Aljadhey), College of Pharmacy, King Saud University, the Pharmacy Service (Al-Kathiri, Aljadhey), King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia, and the Pharmacovigilance Department (Le Louet), Henri Mondor University Hospital (AP-HP), Créteil, France